These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35872236)

  • 1. Society of Family Planning committee consensus on Rh testing in early pregnancy.
    Horvath S; Goyal V; Traxler S; Prager S
    Contraception; 2022 Oct; 114():1-5. PubMed ID: 35872236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
    Hannafin B; Lovecchio F; Blackburn P
    Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization.
    Horvath S; Tsao P; Huang ZY; Zhao L; Du Y; Sammel MD; Prak ETL; Schreiber CA
    Contraception; 2020 Jul; 102(1):1-6. PubMed ID: 32135125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.
    Hsia JK; Schimmoeller NR; Cansino CD; Hou MY; Jensen HM; Creinin MD
    Contraception; 2019 May; 99(5):281-284. PubMed ID: 30500335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetomaternal hemorrhage assessment in Rh-negative patients undergoing dilation and evacuation between 20 and 24 weeks' gestational age: A retrospective cohort study.
    Flynn AN; Hoffman E; Murphy C; Jen A; Schreiber CA; Roe AH
    Contraception; 2022 Jun; 110():27-29. PubMed ID: 35192809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Rh isoimmunization after spontaneous, massive fetomaternal hemorrhage.
    Graham EM; Freedman LJ; Forouzan I; Morgan MA
    South Med J; 1996 Sep; 89(9):911-4. PubMed ID: 8790318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin.
    Hermann M; Kjellman H; Ljunggren C
    Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in Rh prophylaxis. Who needs Rh immune globulin and when should it be given?
    Bowman JM
    Am J Obstet Gynecol; 1985 Feb; 151(3):289-94. PubMed ID: 2982267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Rh immune globulin needed in early first-trimester abortion? A review.
    Jabara S; Barnhart KT
    Am J Obstet Gynecol; 2003 Mar; 188(3):623-7. PubMed ID: 12634631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of foregoing Rh immunoglobulin for bleeding in pregnancy <12 weeks gestation.
    Horvath S; Wang L; Calo W; Yazer MH
    Contraception; 2024 Nov; 139():110530. PubMed ID: 38906503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive feto-maternal haemorrhage: effect of passively administered anti-D in the prevention of Rh sensitization and haemolytic disease of the newborn.
    Mills L; Napier JA
    Br J Obstet Gynaecol; 1988 Oct; 95(10):1007-12. PubMed ID: 2847774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced Abortion and the Risk of Rh Sensitization.
    Horvath S; Huang ZY; Koelper NC; Martinez C; Tsao PY; Zhao L; Goldberg AB; Hannum C; Putt ME; Luning Prak ET; Schreiber CA
    JAMA; 2023 Sep; 330(12):1167-1174. PubMed ID: 37750879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal-Maternal Hemorrhage Detected by Sudden Disappearance of Rh Immune Globulin-Related Anti-D.
    King JR; Zeger GD; Plaza N; Lee RH; Shulman IA
    Obstet Gynecol; 2015 Dec; 126(6):1301-1302. PubMed ID: 26375716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical high-risk designation does not predict excess fetal-maternal hemorrhage.
    Ness PM; Baldwin ML; Niebyl JR
    Am J Obstet Gynecol; 1987 Jan; 156(1):154-8. PubMed ID: 3026183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of significant fetomaternal hemorrhage in patients undergoing cesarean section.
    Feldman N; Skoll A; Sibai B
    Am J Obstet Gynecol; 1990 Sep; 163(3):855-8. PubMed ID: 2169706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal suppression of Rh alloimmunization.
    Bowman JM
    Clin Obstet Gynecol; 1991 Jun; 34(2):296-303. PubMed ID: 1651184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foregoing Rh testing and anti-D immunoglobulin for women presenting for early abortion: a recommendation from the National Abortion Federation's Clinical Policies Committee.
    Mark A; Foster AM; Grossman D; Prager SW; Reeves M; Velásquez CV; Winikoff B
    Contraception; 2019 May; 99(5):265-266. PubMed ID: 30867121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.